A citation-based method for searching scientific literature

C F Samer, K Ing Lorenzini, V Rollason, Y Daali, J A Desmeules. Mol Diagn Ther 2013
Times Cited: 191







List of co-cited articles
618 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
M Bosilkovska, C F Samer, J Déglon, M Rebsamen, C Staub, P Dayer, B Walder, J A Desmeules, Y Daali. Clin Pharmacol Ther 2014
80
18

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
770
14

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
402
13

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
617
13

Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
Marija Bosilkovska, Julien Déglon, Caroline Samer, Bernhard Walder, Jules Desmeules, Christian Staub, Youssef Daali. Bioanalysis 2014
36
27

Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
135
10

Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
249
10

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
190
10

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
474
9



Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
251
9


The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
515
8

Complexities of CYP2D6 gene analysis and interpretation.
Andrea Gaedigk. Int Rev Psychiatry 2013
138
7

Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay. Drug Metab Rev 2009
496
7

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Ulrich M Zanger, Miia Turpeinen, Kathrin Klein, Matthias Schwab. Anal Bioanal Chem 2008
381
7




The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
M C Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, J Chabert, P Dayer, D Hochstrasser, M F Rossier. Pharmacogenomics J 2009
96
6

A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.
Mallorie Clement Jerdi, Youssef Daali, Mitsuko Kondo Oestreicher, Samir Cherkaoui, Pierre Dayer. J Pharm Biomed Anal 2004
60
10

Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
Adrián LLerena, Maria Eugenia G Naranjo, Fernanda Rodrigues-Soares, Eva M Penas-LLedó, Humberto Fariñas, Eduardo Tarazona-Santos. Expert Opin Drug Metab Toxicol 2014
98
6

Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
Marija Bosilkovska, Caroline Samer, Julien Déglon, Aurélien Thomas, Bernhard Walder, Jules Desmeules, Youssef Daali. Basic Clin Pharmacol Toxicol 2016
29
20

Cytochrome P450 variations in different ethnic populations.
Joseph McGraw, Donald Waller. Expert Opin Drug Metab Toxicol 2012
161
6

Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Palrasu Manikandan, Siddavaram Nagini. Curr Drug Targets 2018
213
6

Regulation of drug-metabolizing enzymes and transporters in inflammation.
Alison E Aitken, Terrilyn A Richardson, Edward T Morgan. Annu Rev Pharmacol Toxicol 2006
325
6


Predicting in vivo drug interactions from in vitro drug discovery data.
Larry C Wienkers, Timothy G Heath. Nat Rev Drug Discov 2005
568
6

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
282
5


Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
Roseann S Gammal, Kristine R Crews, Cyrine E Haidar, James M Hoffman, Donald K Baker, Patricia J Barker, Jeremie H Estepp, Deqing Pei, Ulrich Broeckel, Winfred Wang,[...]. Pediatrics 2016
50
10


CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.
D-P Dai, R-A Xu, L-M Hu, S-H Wang, P-W Geng, J-F Yang, L-P Yang, J-C Qian, Z-S Wang, G-H Zhu,[...]. Pharmacogenomics J 2014
81
6


Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
5

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl-Carrillo, W Fraser Symmans, Howard L McLeod, Mark J Ratain, Hitoshi Zembutsu,[...]. Clin Pharmacol Ther 2018
146
5

Pharmacogenomics and individualized drug therapy.
Michel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans. Annu Rev Med 2006
373
5

Cytochrome p450 and chemical toxicology.
F Peter Guengerich. Chem Res Toxicol 2008
942
5

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
497
5

Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.
Flavia Storelli, Caroline Samer, Jean-Luc Reny, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2018
17
29

Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
Gaëlle Magliocco, Aurélien Thomas, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2019
24
20

Drug Metabolism in the Liver.
Omar Abdulhameed Almazroo, Mohammad Kowser Miah, Raman Venkataramanan. Clin Liver Dis 2017
182
5

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
Katherine N Theken, Craig R Lee, Li Gong, Kelly E Caudle, Christine M Formea, Andrea Gaedigk, Teri E Klein, José A G Agúndez, Tilo Grosser. Clin Pharmacol Ther 2020
80
6

Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.
Célia Lloret-Linares, Victoria Rollason, Kuntheavy Ing Lorenzini, Caroline Samer, Youssef Daali, Marianne Gex-Fabry, Jean-Michel Aubry, Jules Desmeules, Marie Besson. Pharmacol Res 2017
8
62

Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
Camille Lenoir, Youssef Daali, Victoria Rollason, François Curtin, Yvonne Gloor, Marija Bosilkovska, Bernhard Walder, Cem Gabay, Michael John Nissen, Jules Alexandre Desmeules,[...]. Clin Pharmacol Ther 2021
15
33


CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
Dana Ravyn, Vipa Ravyn, Robert Lowney, Henry A Nasrallah. Schizophr Res 2013
61
6

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
C F Samer, Y Daali, M Wagner, G Hopfgartner, C B Eap, M C Rebsamen, M F Rossier, D Hochstrasser, P Dayer, J A Desmeules. Br J Pharmacol 2010
106
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.